In-vitro synergistic effect of fluconazole with nonsteroidal anti-inflammatory agents against Candida albicans strains

J Chemother. 2000 Oct;12(5):385-9. doi: 10.1179/joc.2000.12.5.385.

Abstract

The in-vitro interaction and synergistic activity of the combination of fluconazole with some nonsteroidal anti-inflammatory drugs (sodium salicylate, piroxicam, tenoxicam and diclofenac sodium) were investigated in Candida albicans strains (n=7) by the microdilution checkerboard assay. The results were evaluated visually and by a spectrophotometric microplate reader at 492 nm wavelength. Fractional inhibitory index was calculated for every strain and combination according to the minimal inhibitory concentration (MICs). The combination of fluconazole with sodium salicylate, tenoxicam and diclofenac sodium showed synergy against 5, 5 and 3 of the C. albicans strains, respectively. The effect of fluconazole with piroxicam was synergistic against one strain but indifferent/additive against the others. These data suggest that combinations of sodium salicylate, tenoxicam and diclofenac sodium with fluconazole may prove to be useful as chemotherapeutic agents for the treatment of C. albicans infections caused by especially fluconazole-resistant strains. However, additional preclinical work and in vivo studies are necessary to determine their definite clinical use.

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology*
  • Antifungal Agents / pharmacology*
  • Candida albicans / drug effects*
  • Diclofenac / pharmacology
  • Drug Synergism
  • Fluconazole / pharmacology*
  • Humans
  • Microbial Sensitivity Tests
  • Piroxicam / analogs & derivatives*
  • Piroxicam / pharmacology
  • Sodium Salicylate / pharmacology

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Antifungal Agents
  • Piroxicam
  • Diclofenac
  • Fluconazole
  • Sodium Salicylate
  • tenoxicam